 |
|
Common bacteria activating natural killer T cells may cause autoimmune liver disease
May 15, 2008Researchers close in on possible cause of primary biliary cirrhosis
CINCINNATI - A bacteria commonly found in soil and water triggered autoimmune symptoms in mice similar to those found in an incurable liver disease called Primary Biliary Cirrhosis (PBC). Reporting their findings in the May 15 Cell Host & Microbe, the multi-institutional research team said injecting laboratory mice with the bacterium - Novosphingobium aromaticivorans - prompted activation of Natural Killer T (NKT) cells, which were critical to initiating autoimmune processes that led to liver disease.
Besides pointing to a possible cause for PBC, the study also provides scientists a model that will enhance future research of this and other autoimmune disorders, said Jochen Mattner, M.D., a physician and researcher in the Division of Immunobiology at Cincinnati Children's Hospital Medical Center and lead author of the study.
Undetected infections are increasingly pointed to in ongoing research as possible triggers of autoimmune disease, in which the immune system - designed to fight infection or disease - instead attacks the body's own tissues. Precisely how microbes (such as bacteria or viruses) engage cellular and molecular processes to cause autoimmunity remains unknown, as does the cause of PBC. PBC results in inflammatory lesions within the portal fields and subsequent destruction of small bile ducts of the liver.
"Our study of autoimmunity in PBC showed that NKT cells react to glycosphingolipid antigens, which promote cell attraction and immune response and are located in the bacterial cell wall of Novosphingobium aromaticivorans. This microbial activation of NKT cells was as an essential trigger of autoimmune processes that led to disease-like symptoms in mice," said Dr. Mattner, who started the study at the University of Chicago. "We aren't suggesting this bacterium is the only possible cause of PBC, but it does present a model having significant implications for understanding immunological tolerance and autoimmunity."
Previous research has shown that patients with PBC have a buildup of certain autoantibodies that attack an enzyme complex found in mitochondria, which are the energy source of most cells. Those same autoantibodies also cross react with a corresponding enzyme of Novosphingobium aromaticivorans, an alpha-proteobacterium with an evolutionary relationship to mitochondria. This relationship has led researchers in previous studies to suggest that Novosphingobium aromaticivorans may have a role in PBC, and it was a factor in Dr. Mattner's research team using the bacterium in this study.
When the researchers injected mice with the bacterium, it prompted the production of autoantibodies against the mitochondrial enzyme complex in similar fashion to that observed in patients. This triggered chronic autoimmunity that damaged small bile ducts in the animal's livers. The autoimmune process was mediated by T cells (a white blood cell important to immune response), but early disease onset required the participation of Natural Killer T cells after they selectively recognized glycosphingolipid antigens on the cell wall surface of Novosphingobium aromaticivorans. NKT cells are a unique group of T cells that share properties of both T cells and Natural Killer cells, which are naturally toxic to other cells and typically target tumor cells or cells infected with viruses. The natural presence of NKT cells in the liver, combined with an accumulation of Novosphingobium aromaticivorans, likely explains why the liver is damaged during this autoimmune process, Dr. Mattner said.
After the research team established chronic autoimmune liver disease in mice, they performed studies to see if they could transfer the disease with spleen T cells from infected livers into a second group of mice. T cells from mice having CD1d (a glycoprotein important to activating NKT cells) caused autoimmune liver disease in recipient mice, although cells from CD1d deficient mice (which lack NKT cells) did not. Dr. Mattner said this result illustrates the importance of early microbial activation of NKT cells in the early stages of autonomous, organ-specific autoimmunity. Although NKT cells were not critical to transferring already established disease, they are extremely important in the early onset stages by helping break down the body's tolerance for infection, the researchers said.
The researchers were also able to prevent or slow autoimmune liver disease in some mice, either by early intervention with antibiotics, or by deleting the gene that encodes the CD1d glycoprotein and its activation of NKT cell attraction to Novosphingobium aromaticivorans.
PBC is relatively rare, occurring in about five of every 100,000 people. Disease prevalence and rate of occurrence vary in different regions of the world. About 90 percent of patients are women, and the disease is more common in patients between 40 and 60 years old. Patients typically experience itching, jaundice and can have increased blood pressure that leads to fluid retention in the abdomen, as well as other symptoms. Because there is no cure for PBC, treatment focuses mostly on trying to alleviate symptoms with medication, or in some cases liver transplant in the event of organ failure.
Cincinnati Children's Hospital Medical Center
Undetected infections are increasingly pointed to in ongoing research as possible triggers of autoimmune disease, in which the immune system - designed to fight infection or disease - instead attacks the body's own tissues. Precisely how microbes (such as bacteria or viruses) engage cellular and molecular processes to cause autoimmunity remains unknown, as does the cause of PBC. PBC results in inflammatory lesions within the portal fields and subsequent destruction of small bile ducts of the liver.
"Our study of autoimmunity in PBC showed that NKT cells react to glycosphingolipid antigens, which promote cell attraction and immune response and are located in the bacterial cell wall of Novosphingobium aromaticivorans. This microbial activation of NKT cells was as an essential trigger of autoimmune processes that led to disease-like symptoms in mice," said Dr. Mattner, who started the study at the University of Chicago. "We aren't suggesting this bacterium is the only possible cause of PBC, but it does present a model having significant implications for understanding immunological tolerance and autoimmunity."
Previous research has shown that patients with PBC have a buildup of certain autoantibodies that attack an enzyme complex found in mitochondria, which are the energy source of most cells. Those same autoantibodies also cross react with a corresponding enzyme of Novosphingobium aromaticivorans, an alpha-proteobacterium with an evolutionary relationship to mitochondria. This relationship has led researchers in previous studies to suggest that Novosphingobium aromaticivorans may have a role in PBC, and it was a factor in Dr. Mattner's research team using the bacterium in this study.
When the researchers injected mice with the bacterium, it prompted the production of autoantibodies against the mitochondrial enzyme complex in similar fashion to that observed in patients. This triggered chronic autoimmunity that damaged small bile ducts in the animal's livers. The autoimmune process was mediated by T cells (a white blood cell important to immune response), but early disease onset required the participation of Natural Killer T cells after they selectively recognized glycosphingolipid antigens on the cell wall surface of Novosphingobium aromaticivorans. NKT cells are a unique group of T cells that share properties of both T cells and Natural Killer cells, which are naturally toxic to other cells and typically target tumor cells or cells infected with viruses. The natural presence of NKT cells in the liver, combined with an accumulation of Novosphingobium aromaticivorans, likely explains why the liver is damaged during this autoimmune process, Dr. Mattner said.
After the research team established chronic autoimmune liver disease in mice, they performed studies to see if they could transfer the disease with spleen T cells from infected livers into a second group of mice. T cells from mice having CD1d (a glycoprotein important to activating NKT cells) caused autoimmune liver disease in recipient mice, although cells from CD1d deficient mice (which lack NKT cells) did not. Dr. Mattner said this result illustrates the importance of early microbial activation of NKT cells in the early stages of autonomous, organ-specific autoimmunity. Although NKT cells were not critical to transferring already established disease, they are extremely important in the early onset stages by helping break down the body's tolerance for infection, the researchers said.
The researchers were also able to prevent or slow autoimmune liver disease in some mice, either by early intervention with antibiotics, or by deleting the gene that encodes the CD1d glycoprotein and its activation of NKT cell attraction to Novosphingobium aromaticivorans.
PBC is relatively rare, occurring in about five of every 100,000 people. Disease prevalence and rate of occurrence vary in different regions of the world. About 90 percent of patients are women, and the disease is more common in patients between 40 and 60 years old. Patients typically experience itching, jaundice and can have increased blood pressure that leads to fluid retention in the abdomen, as well as other symptoms. Because there is no cure for PBC, treatment focuses mostly on trying to alleviate symptoms with medication, or in some cases liver transplant in the event of organ failure.
Cincinnati Children's Hospital Medical Center
Autoimmune Current Events and Autoimmune News RSSJDRF funded study links 'hygiene hypothesis' to diabetes prevention
A research study funded by JDRF suggests that a common intestinal bacteria may provide some protection from developing type 1 diabetes. The findings provide an important step towards understanding how and why type 1 diabetes develops in people, and may lead to potential cures.
DNA of good bacteria drives intestinal response to infection
A new study shows that the DNA of so-called "good bacteria" that normally live in the intestines may help defend the body against infection.
An ethical argument: Include pregnant women in research
Why aren't pregnant women included in most clinical trials? That's the question posed by leading bioethicists at Duke University Medical Center, Johns Hopkins and Georgetown Universities, who say it's time to confront the challenges that have led to the exclusion of pregnant women from important research that could positively impact maternal and fetal health.
New mechanism for cardiac arrhythmia discovered
It has long been thought that virus infections can cause cardiac arrhythmia. But why has not been understood. Ulrike Lisewski, Dr. Yu Shi, Michael Radke and Professor Michael Gotthardt of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch, Germany, have now discovered the molecular mechanism.
Wistar researchers invigorate 'exhausted' immune cells
In battles against chronic infections, the body's key immune cells often become exhausted and ineffective. Researchers at The Wistar Institute have found a way to restore vigor to these killer T cells by blocking a key receptor on their surface, findings that may advance the development of new therapies for diseases such as HIV, hepatitis B and C, and cancer.
Survival instincts propel 'difficult patient' to insist on quality care
Michelle Mayer had to become a "difficult patient" before she could get her physicians to accurately diagnose the disease that was destroying her health.
Monitoring immune responses in disease
A recent study published in Clinical Immunology, the official journal of the Clinical Immunology Society (CIS), describes a new method enabling the detection of multiple parameters of single human cells.
Loss of sleep, even for a single night, increases inflammation in the body
Loss of sleep, even for a few short hours during the night, can prompt one's immune system to turn against healthy tissue and organs.
New role for Natural Killers!
Scientists at the University of York have discovered a new role for a population of white blood cells, which may lead to improved treatments for chronic infections and cancer.
Early trigger for type-1 diabetes found in mice, Stanford scientists report
Scientists at the Stanford University School of Medicine are shedding light on how type-1 diabetes begins.
More Autoimmune Current Events and Autoimmune News Articles
 | The Autoimmune Epidemic: Bodies Gone Haywire in a World Out of Balance--and the Cutting-Edge Science that Promises Hope by Donna Jackson Nakazawa From the foreword by Dr. Douglas Kerr, Director, Johns Hopkins Transverse Myelitis Center "The Autoimmune Epidemic by Donna Jackson Nakazawa is an astounding book....It is the kind of book that will rivet you and scare you. It will make you angry. It will amaze you with the courage of some of the people described in the book...The Autoimmune Epidemic is every bit as compelling as Upton Sinclair's... |
 | Living Well with Autoimmune Disease: What Your Doctor Doesn't Tell You...That You Need to Know by Mary J. Shomon A complete guide to understanding the mysterious and often difficult-to-pinpoint disorders of the immune system--and finding the keys to diagnosis, treatment, and recovery. An estimated fifty million people suffer from symptoms including fatigue, joint pains, depression, or heart palpitations — signs that the immune system has turned on itself, causing conditions such as thyroid disease,... |
 | Women, Work, and Autoimmune Disease: Keep Working, Girlfriend! by Rosalind Joffe, Joan Friedlander When a woman receives a life-changing diagnosis of a serious, chronic illness, her first instinct may be to quit the workforce. This may bring a strong sense of relief initially, but as her disease becomes manageable, work is again desirable. Women, Work, and Autoimmune Disease urges women so affected to stay employed in order to preserve their independence and sense of self. Filled with tips,... |
 | What Your Doctor May Not Tell You About Autoimmune Disorders: The Revolutionary, Drug-Free Treatments for Thyroid Disease, Lupus, MS, IBD, Chronic Fatigue; Rheumatoid Arthritis, and Other Diseases by Stephen B. Edelson, Deborah Mitchell Autoimmune disorders are not well understood and therefore difficult to treat. The result is that there are millions of Americans who are suffering because they aren't being diagnosed properly, or getting the correct medical treatment they need. Here, Dr. Edelson discusses the most common types of autoimmune diseases, including lupus, Chron's disease, thyroid disease, rheumatoid arthritis, and... |
 | The Autoimmune Connection by Rita Baron-Faust, Jill P. Buyon As featured in the New York Times and recommended by the National Women's Health Resource Center and the Society for Women's Health Research, The Autoimmune Connection discusses the links between autoimmune diseases and offers up-to-date information on diagnosis, treatments, and risks for women with one or more autoimmune disease, such as lupus, rheumatoid arthritis, or Crohn's... |
 | Women and Autoimmune Disease: The Mysterious Ways Your Body Betrays Itself by Robert G. Lahita, Ina L. Yalof A cutting-edge examination of the mysterious world of autoimmune disease—and the new discoveries made daily that may save women's lives Autoimmune diseases—including chronic fatigue syndrome, vasculitis, juvenile diabetes, alopecia, Graves' disease, Sjogren's syndrome, lupus, rheumatoid arthritis, and multiple sclerosis—are among the most devastating conditions afflicting women today and... |
 | The Lupus Recovery Diet: A Natural Approach to Autoimmune Disease That Really Works by Jill Harrington This could be the most important book you'll ever read if you, or someone you love, has lupus. Jill Harrington, the author, recovered from lupus over twelve years ago, using a specific diet and lifestyle. And... she's not the only one. You will read the stories of other people who have done the same thing. It isn't widely known how much of an effect the foods you eat can have on lupus and other... |
| Friendly Fire: Explaining Autoimmune Disease by David Isenberg, John Morrow This book deals with a fascinating set of diseases in which the immune system turns traitor and begins to attack the self. The attack may take many forms, culminating in serious skin disease, or disease affecting the joints, heart, lungs, kidneys, and central nervous system, to name only a few of the possibilities. The reader is given a short historical guide to these conditions, followed by a... | |
 | The Official Patient's Sourcebook on Autoimmune Hepatitis: A Revised and Updated Directory for the Internet Age by Icon Health Publications This book has been created for patients who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells patients where and how to look for information covering virtually all topics related to autoimmune hepatitis (also acute viral hepatitis A; alcoholic... |
 | Thriving With Your Autoimmune Disorder: A Woman's Mind-Body Guide by Simone Ravicz Ph.D. M.B.A. Women facing chronic pain and illness due to multiple sclerosis, rheumatoid arthritis, chronic fatigue, and other autoimmune disorders have a new place to look for encouragement. In this comprehensive and caring guide, Simone Ravicz presents a wide range of suggestions for not merely enduring illness but finding ways to thrive in spite of it. Ravicz herself suffers from autoimmune disorders. As... |
| © 2008 BrightSurf.com |